Molecular Partners Ag (MOLN) Prepaid Assets (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Prepaid Assets of $2358.6 for Q1 2026, up 2.49% year-over-year from $2301.2 in Q1 2025, and down 5.03% quarter-over-quarter from $2483.6 in Q4 2025.
Molecular Partners Ag (MOLN) Prepaid Assets (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Prepaid Assets for 7 consecutive years, with $2358.6 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 2.49% year-over-year to $2358.6; the TTM figure through Mar 2026 stood at $2358.6 (up 2.49% YoY), while the FY2025 annual figure was $2483.6, down 99.91% from the prior year.
- Prepaid Assets fell to $2358.6 in Q1 2026 per MOLN's latest filing, from $2483.6 in the prior quarter.
- Across five years, Prepaid Assets topped out at $4.8 million in Q4 2022 and bottomed at $2301.2 in Q1 2025.
- Historically, Prepaid Assets has averaged $1.4 million across 5 years, with a median of $3988.6 in 2023.
- Annual changes were most pronounced in 2023 — Prepaid Assets advanced 15.9% — and 2025, when it sank 99.91%.
- Molecular Partners Ag's Prepaid Assets stood at $4.8 million in 2022, then dropped by 14.4% to $4.1 million in 2023, then decreased by 29.31% to $2.9 million in 2024, then tumbled by 99.91% to $2483.6 in 2025, then decreased by 5.03% to $2358.6 in 2026.
- Business Quant data shows MOLN's Prepaid Assets at $2358.6 in Q1 2026, $2483.6 in Q4 2025, and $2919.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,358.63 |
| Dec 31, 2025 | 2,483.57 |
| Sep 30, 2025 | 2,919.01 |
| Jun 30, 2025 | 2,989.53 |
| Mar 31, 2025 | 2,301.25 |
| Dec 31, 2024 | 2.88 Mn |
| Sep 30, 2024 | 2,995.17 |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 3,292.69 |
| Dec 31, 2023 | 4.08 Mn |
| Sep 30, 2023 | 3,988.57 |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 3,635.95 |
| Dec 31, 2022 | 4.76 Mn |
| Sep 30, 2022 | 4,995.04 |
| Jun 30, 2022 | 3.99 Mn |
| Mar 31, 2022 | 4,207.79 |
| Dec 31, 2021 | 6.21 Mn |
| Sep 30, 2021 | 8,512.63 |
| Dec 31, 2020 | 1,387.12 |